摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-dimethylaminobutanoic acid [4-(5-chloro-4-fluoro-3-methylphenylamino)-3-methyl-7-methoxyquinolin-6-yl]amide hydrochloride | 1050672-70-2

中文名称
——
中文别名
——
英文名称
4-dimethylaminobutanoic acid [4-(5-chloro-4-fluoro-3-methylphenylamino)-3-methyl-7-methoxyquinolin-6-yl]amide hydrochloride
英文别名
——
4-dimethylaminobutanoic acid [4-(5-chloro-4-fluoro-3-methylphenylamino)-3-methyl-7-methoxyquinolin-6-yl]amide hydrochloride化学式
CAS
1050672-70-2
化学式
C24H28ClFN4O2*ClH
mdl
——
分子量
495.424
InChiKey
PRXRSHFPUAFJCN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.1
  • 重原子数:
    33.0
  • 可旋转键数:
    8.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    66.49
  • 氢给体数:
    2.0
  • 氢受体数:
    5.0

反应信息

  • 作为产物:
    描述:
    4-(3-methyl-4-fluoro-5-chlorophenylamino)-7-methoxy-6-aminoquinoline-3-methyl hydrochloride4-(dimethylamino)butanoyl chlorideN,N-二异丙基乙胺 作用下, 以 四氢呋喃 为溶剂, 以13.5 g的产率得到4-dimethylaminobutanoic acid [4-(5-chloro-4-fluoro-3-methylphenylamino)-3-methyl-7-methoxyquinolin-6-yl]amide hydrochloride
    参考文献:
    名称:
    Redesigning Kinase Inhibitors to Enhance Specificity
    摘要:
    Kinases are important targets in molecular cancer therapy. However, the evolutionary relatedness and structural conservation of these proteins often lead to unforeseen cross reactivity, yielding unexpected side effects. Thus, the use of promiscuous drugs is likely to introduce dangerous clinical uncertainties. Here, we show how to rationally redesign two promiscuous kinase inhibitors, staurosporine (7) and EKB-569 (8), with the goal of turning, them into more selective ligands. This problem is addressed by exploiting a structure-based selectivity filter for specificity: the pattern of packing defects in the target. These singularities, called dehydrons, are solvent-exposed intramolecular hydrogen bonds that may be protected by drugs upon association and are not conserved across protein families. Our redesigned compounds possess a significantly focused activity, as experimentally corroborated in high-throughput screening assays. Thus, our design strategy proves to be operative to reduce the inhibitory impact of promiscuous kinase ligands, enhancing their safety as therapeutic agents.
    DOI:
    10.1021/jm800453a
点击查看最新优质反应信息